Analysis: Gilbert Cisneros's purchase of RVTY (Revvity, Inc.)

Assessment: On watch

Notable size escalation in a diagnostics firm following a relevant biosecurity hearing, but heavily diluted by high-churn baseline and public earnings timing.

Member: Gilbert Cisneros
Party / state: Democratic-CA31
Chamber: Representatives
Transaction: Purchase
Amount: $15,001 - $50,000
Ticker: RVTY
Company: Revvity, Inc.
Trade date: 2026-05-04
Disclosure date: 2026-06-08
Disclosure lag: 35 days

Executive summary

Rep. Gilbert Cisneros, a member of the Armed Services Committee, increased his position in Revvity (RVTY) with a $15,001-$50,000 purchase on May 4, 2026. This trade followed a string of smaller purchases and occurred shortly after an Armed Services hearing regarding biosecurity and laboratory modernization. The purchase was executed immediately following the company's Q1 earnings report.

The trade marks a significant escalation in Cisneros's conviction in RVTY, representing his largest single purchase of the ticker to date. Notably, the purchase was timed four days after the company's Q1 earnings release and six days after a relevant Armed Services hearing on laboratory capabilities for biological defense, a sector where Revvity operates. While other members like Ro Khanna also showed interest in the ticker during the same period, Cisneros's role on the Intelligence and Special Operations subcommittee provides him with oversight of biosecurity threats discussed in recent committee sessions. The stock has appreciated approximately 13% since the trade, outperforming the SPY significantly.

Timeline

2026-04-13 — Rep. Ro Khanna buys RVTY
2026-04-28 — House Armed Services hearing on Biosecurity/Laboratory Capabilities
2026-04-30 — Revvity Q1 2026 Earnings Release
2026-05-01 — Rep. Cisneros buys RVTY ($1k-$15k)
2026-05-04 — Rep. Cisneros buys RVTY ($15k-$50k) [Analyzed Trade]

Independent analysis of public financial disclosures. Not financial or investment advice.

Sources

Gilbert Cisneros · RVTY · Trading news